The Latest Dialysis Industry Statistics Explained
Dialysis Market size was valued at USD 85 billion in 2018.
The statistic “Dialysis market size was valued at USD 85 billion in 2018” indicates the total monetary value of the global market for dialysis products and services in the year 2018. This figure reflects the revenue generated from the sale of dialysis equipment, consumables, and treatments across various regions. The size of the dialysis market provides insight into the scale and importance of the industry, showing significant demand for dialysis therapies due to the rising prevalence of chronic kidney diseases worldwide. It also serves as a key metric for investors, healthcare professionals, policymakers, and other stakeholders to understand the economic impact and growth potential within the dialysis sector.
The global dialysis market is projected to reach USD 118.5 billion by 2023.
The statistic states that the global dialysis market is forecasted to grow and reach a value of USD 118.5 billion by the year 2023. This figure represents the total economic value of products and services related to dialysis treatment worldwide. The growth in the dialysis market can be attributed to factors such as an increasing prevalence of chronic kidney disease, a growing aging population, advancements in technology for dialysis treatment, and expanding access to healthcare services in developing economies. This projection indicates a significant market opportunity for companies operating in the dialysis sector and reflects the continued demand for dialysis services to support individuals with kidney-related health issues on a global scale.
North America dominates the dialysis market due to advanced healthcare infrastructure.
The statistic “North America dominates the dialysis market due to advanced healthcare infrastructure” indicates that the majority of the market share for dialysis products and services in the region of North America is held by businesses, hospitals, and healthcare providers. This dominance is attributed to the advanced healthcare infrastructure present in North America, which includes well-equipped facilities, skilled professionals, and advanced medical technologies. As a result, North America is able to offer high-quality dialysis treatments to a large population, leading to its prominence in the market. This statistic underscores the importance of healthcare infrastructure in shaping market dynamics and influencing the provision of essential healthcare services such as dialysis in a particular region.
Asia Pacific is expected to be the fastest-growing region in the dialysis market.
The statistic indicates that the Asia Pacific region is projected to experience the highest rate of growth within the dialysis market compared to other regions. This suggests that there will likely be an increasing demand for dialysis services and products in the Asia Pacific region due to factors such as rising prevalence of chronic kidney disease, improving healthcare infrastructure, increasing geriatric population, and changing lifestyle factors. Companies operating in the dialysis market may therefore want to focus on expanding their presence and investments in this region to capitalize on the anticipated growth opportunities.
There were 2.6 million people worldwide receiving dialysis in 2014.
The statistic indicates that in 2014, there were approximately 2.6 million individuals globally who were undergoing dialysis treatment, a medical procedure used to filter waste and remove excess fluid from the blood when the kidneys are no longer able to perform this function adequately. The high number of people receiving dialysis highlights the widespread prevalence of chronic kidney disease and related conditions that require ongoing treatment to maintain health and quality of life. This statistic serves as an important indicator of the burden of kidney disease on a global scale and underscores the need for continued efforts to improve access to healthcare services, raise awareness about kidney health, and support research initiatives aimed at developing better treatment strategies for affected individuals.
The global dialysis population is predicted to grow to 5.4 million by 2030.
The statistic that the global dialysis population is predicted to grow to 5.4 million by 2030 indicates the projected increase in the number of individuals worldwide who will require dialysis treatment for managing end-stage kidney disease. This growth implies a significant rise in the prevalence of chronic kidney disease and related health conditions globally. The forecasted expansion of the dialysis population highlights the pressing need for improved healthcare infrastructure, resources, and access to renal replacement therapy to address the escalating demand for dialysis services in the coming decade. Policymakers, healthcare providers, and stakeholders in the healthcare industry should take proactive measures to meet the anticipated rise in the demand for dialysis treatment and ensure that adequate care and support are available for individuals with kidney disease.
There are about 594,000 Americans relying on dialysis for treatment.
The statistic that approximately 594,000 Americans rely on dialysis for treatment represents the number of individuals in the United States who require this life-saving medical procedure to manage their kidney failure. Dialysis is a treatment that helps filter and remove waste and excess fluids from the blood when the kidneys are unable to perform this function adequately. This statistic highlights the significant impact of kidney disease on a large portion of the population in the US, as well as the importance of access to dialysis services for maintaining the health and well-being of those affected. It also underscores the ongoing need for awareness, prevention, and treatment of kidney diseases to improve outcomes and quality of life for individuals requiring dialysis.
Home dialysis is expected to be the fastest growing segment, exhibiting a CAGR of approximately 6.5% from 2016 to 2024.
The statement regarding home dialysis being the fastest growing segment with a Compound Annual Growth Rate (CAGR) of approximately 6.5% from 2016 to 2024 indicates that there is a projected annual increase of 6.5% in the number of individuals opting for home dialysis over this period. This growth rate suggests a significant shift towards home-based dialysis treatments and signifies a rising trend in the preference for this form of treatment compared to other dialysis options. The statistic reflects a positive outlook for the home dialysis market, highlighting an increasing demand for more convenient and flexible dialysis options among individuals with renal health issues.
In Europe, 25 to 35% of patients start dialysis annually in a state of emergency.
The statistic that 25 to 35% of patients in Europe start dialysis annually in a state of emergency indicates a concerning trend in the healthcare system. This high percentage suggests that a significant proportion of patients are not receiving timely or effective preventive care for kidney disease, resulting in the need for emergency dialysis. Starting dialysis in an emergency situation can place additional strain on both patients and healthcare providers, potentially leading to poorer health outcomes and increased healthcare costs. This statistic underscores the importance of improving access to preventive care and early interventions for kidney disease to reduce the number of patients requiring emergency dialysis and improve overall patient outcomes in Europe.
Approximately 80% of the world’s dialysis patients are treated with products from Fresenius Medical Care.
The statistic indicates that a large majority, around 80%, of the global dialysis market is dominated by products from Fresenius Medical Care, a major healthcare company specializing in dialysis treatment. This suggests that Fresenius Medical Care plays a significant role in providing critically needed dialysis services to patients worldwide. The high market share could be attributed to various factors such as the company’s established reputation for quality products, widespread availability, effective marketing strategies, or strong relationships with healthcare providers. Overall, the statistic highlights Fresenius Medical Care’s leading position in the dialysis industry and its substantial impact on the treatment of patients with kidney-related conditions.
The average U.S. dialysis patient incurs about $87,565 in annual medical costs.
The statistic that the average U.S. dialysis patient incurs about $87,565 in annual medical costs represents the average amount of money spent on healthcare services and treatments related to dialysis for this specific patient population over the course of a year. Dialysis is a treatment process that helps filter and remove waste and excess fluids from the blood when the kidneys are no longer able to perform this function, often due to kidney failure. The high annual cost of $87,565 underscores the significant financial burden faced by dialysis patients and highlights the substantial expenses associated with managing chronic kidney disease. This statistic is crucial for policymakers, healthcare providers, and patients themselves in understanding the financial impact and challenges faced by individuals requiring dialysis treatment in the United States.
Europe holds the second highest dialysis market share after North America.
This statistic indicates that Europe has the second largest market share in the global dialysis industry, with North America holding the highest market share. This suggests that Europe is a significant player in the dialysis market, trailing closely behind North America. The high market share in Europe likely reflects a combination of factors such as the prevalence of kidney disease in the region, the availability and adoption of dialysis technologies and treatments, as well as healthcare infrastructure and policies that support dialysis services. Companies operating in this industry may find Europe to be a lucrative market for dialysis products and services, given its substantial market share.
The five year survival rate for dialysis patients is around 35%.
The statistic that the five year survival rate for dialysis patients is around 35% indicates that approximately 35 out of every 100 patients undergoing dialysis treatment are expected to survive for at least five years following the initiation of the treatment. This statistic suggests that survival outcomes for dialysis patients are generally poor, highlighting the challenges and risks associated with managing end-stage renal disease through dialysis therapy. Factors such as age, coexisting medical conditions, adherence to treatment, and access to healthcare services can all influence a patient’s chances of survival on dialysis. The statistic underscores the importance of early detection, proactive management, and ongoing support for individuals undergoing dialysis to improve their long-term outcomes and quality of life.
In the UK, there were over 29,000 patients on dialysis in 2016.
The statistic states that in the United Kingdom in 2016, there were more than 29,000 individuals receiving dialysis treatment. Dialysis is a medical procedure used to help individuals with impaired kidney function filter waste and excess fluids from their blood. The high number of patients on dialysis in the UK in 2016 highlights the significant burden of kidney disease in the population. The statistic underscores the importance of healthcare services and support for individuals with kidney issues and the need for continued efforts in prevention, early detection, and treatment of kidney disease in the country.
41% of U.S. kidney patients receive dialysis at a center.
The statistic ‘41% of U.S. kidney patients receive dialysis at a center’ indicates the proportion of kidney patients in the United States who undergo dialysis treatment at a healthcare facility such as a dialysis center. Dialysis is a vital medical procedure for individuals with kidney failure, as it helps to filter waste and excess fluids from the blood when the kidneys are unable to perform this function. The fact that 41% of kidney patients receive dialysis at a center suggests that a significant portion of the population with kidney-related health issues requires specialized medical care and monitoring provided by dialysis centers. This statistic highlights the widespread impact of kidney disease in the U.S. and the critical role that dialysis centers play in managing and treating this condition.
By 2028, the global dialysis market is expected to reach USD 142.28 billion.
The statistic ‘By 2028, the global dialysis market is expected to reach USD 142.28 billion’ is a projection of the anticipated value of the global market for dialysis services and equipment by the year 2028. This figure represents the estimated total amount of money that is projected to be spent on dialysis-related products and services across the world. The high expected value of USD 142.28 billion indicates a significant and growing demand for dialysis treatments due to factors such as an aging population, rising prevalence of chronic kidney disease, and increasing access to healthcare services globally. This projection serves as an important indicator for healthcare providers, policymakers, and investors in understanding the market trends and potential opportunities in the field of dialysis.
Hemodialysis holds the largest share, accounting for over 85% of dialysis treatment procedures worldwide.
This statistic indicates that hemodialysis is the predominant method for providing dialysis treatment globally, encompassing a substantial majority of over 85% of all dialysis procedures performed worldwide. Hemodialysis involves filtering a patient’s blood through a specialized machine to remove waste products and excess fluids when the kidneys are no longer able to perform this function adequately. Its widespread use can be attributed to factors such as its effectiveness in managing kidney failure, its relatively established infrastructure and accessibility in healthcare settings, as well as its ability to efficiently remove toxins from the blood. This statistic underscores the significant role that hemodialysis plays in the management of kidney disease on a global scale.
Only 12% of dialysis patients are undergoing home dialysis as of 2020.
The statistic indicates that as of 2020, only 12% of dialysis patients are choosing to undergo home dialysis. This suggests that a majority of dialysis patients are still opting for in-center hemodialysis or peritoneal dialysis, which are typically administered in a clinical setting. The relatively low percentage of patients choosing home dialysis may reflect barriers or challenges associated with this treatment option, such as the need for specialized training, concerns about managing the treatment at home, limited access to support services, or a lack of awareness about the benefits of home dialysis. Increased education, improved support services, and addressing barriers to home dialysis could potentially help more patients access this alternative treatment option.
Dialysis centers generated around $24.7 billion in revenue in 2019 in the U.S.
The statistic that dialysis centers generated around $24.7 billion in revenue in the U.S. in 2019 indicates the significant financial impact and scale of the dialysis industry within the country during that year. This revenue figure reflects the total earnings generated by facilities that provide dialysis treatment services for individuals with kidney disease or failure. The substantial revenue suggests a high demand for dialysis services among the population, likely due to factors such as the prevalence of chronic kidney disease, increasing aging population, and advances in medical technology. The statistic underscores the economic importance of the dialysis sector within the healthcare industry and highlights the financial resources involved in providing life-saving treatment to patients in need of regular dialysis sessions.
References
0. – https://www.www.pharmiweb.com
1. – https://www.www.datamintelligence.com
2. – https://www.www.fortunebusinessinsights.com
3. – https://www.www.renal.org
4. – https://www.www.marketsandmarkets.com
5. – https://www.ajkdblog.org
6. – https://www.www.gminsights.com
7. – https://www.www.cdc.gov
8. – https://www.www.ncbi.nlm.nih.gov
9. – https://www.www.kidney.org
10. – https://www.www.grandviewresearch.com
11. – https://www.www.psmarketresearch.com
12. – https://www.newsroom.uhc.com
13. – https://www.www.freseniusmedicalcare.com
14. – https://www.www.researchandmarkets.com
15. – https://www.www.ibisworld.com
